Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors

• Christopher B. Cole,
• Maria Pia Morelli,
• Massimo Fantini,
• Markku Miettinen,
• Patricia Fetsch,
• Cody Peer,
• William D. Figg,
• Tyler Yin,
• Nicole Houston,
• Ann McCoy,
• Stanley Lipkowitz,
• Alexandra Zimmer,
• Jung-min Lee,
• Miroslava Pavelova,
• Erin N. Villanueva,
• Kathryn Trewhitt,
• B. Brooke Solarz,
• Maria Fergusson,
• Sharon A. Mavroukakis,
• Anjum Zaki,
• Kwong Y. Tsang,
• Philip M. Arlen,
• Christina M. Annunziata

Affiliations

Christopher B. Cole

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Maria Pia Morelli

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Massimo Fantini

Precision Biologics, Inc

Markku Miettinen

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Patricia Fetsch

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Cody Peer

Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health

William D. Figg

Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health

Tyler Yin

Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health

Nicole Houston

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Ann McCoy

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Stanley Lipkowitz

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Alexandra Zimmer

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Jung-min Lee

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Miroslava Pavelova

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Erin N. Villanueva

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Kathryn Trewhitt

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

B. Brooke Solarz

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Maria Fergusson

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Sharon A. Mavroukakis

Precision Biologics, Inc

Anjum Zaki

Precision Biologics, Inc

Kwong Y. Tsang

Precision Biologics, Inc

Philip M. Arlen

Precision Biologics, Inc

Christina M. Annunziata

Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health